Discontinuation report MAR-METFORMIN
| Report ID | 54712 |
| Drug Identification Number | 02378620 |
| Brand name | MAR-METFORMIN |
| Common or Proper name | MAR-Metformin |
| Company Name | MARCAN PHARMACEUTICALS INC |
| Market Status | CANCELLED POST MARKET |
| Active Ingredient(s) | METFORMIN HYDROCHLORIDE |
| Strength(s) | 500MG |
| Dosage form(s) | TABLET |
| Route of administration | ORAL |
| Packaging size | 100 Tabs |
| ATC code | A10BA |
| ATC description | BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS |
| Reason for discontinuation | Business reasons |
| Anticipated discontinuation date | 2018-08-06 |
| Actual discontinuation date | 2018-08-07 |
| Remaining supply date | 2018-07-09 |
| Discontinuation status | Discontinued |
| Discontinuation decision reversal | No |
| Information on remaining supply | |
| Company comments | To be Discontinued |
| Health Canada comments | |
| Contact Address | 2 GURDWARA RD., SUITE 112 OTTAWA, ONTARIO CANADA K2E 1A2 |
| Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.